The Dinakara equation for adjusting DLCO for hemoglobin in the HCT-CI is superior to the Cotes equation for predicting high-risk patients in allogeneic hematopoietic stem cell transplantation

Haider Mahnur; Gangat Naseema; Hanson Curtis; Tefferi Ayalew

首页> 外文期刊>American Journal of Hematology >The Dinakara equation for adjusting DLCO for hemoglobin in the HCT-CI is superior to the Cotes equation for predicting high-risk patients in allogeneic hematopoietic stem cell transplantation

【24h】

The Dinakara equation for adjusting DLCO for hemoglobin in the HCT-CI is superior to the Cotes equation for predicting high-risk patients in allogeneic hematopoietic stem cell transplantation

机译：在HCT-CI中用于调节血红蛋白DLCO的Dinakara方程优于预测同种异体造血干细胞移植中高危患者的Cotes方程

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《American Journal of Hematology》 |2016年第5期|共2页
作者
Haider Mahnur; Gangat Naseema; Hanson Curtis; Tefferi Ayalew;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The Dinakara equation for adjusting DLCO for hemoglobin in the HCT-CI is superior to the Cotes equation for predicting high-risk patients in allogeneic hematopoietic stem cell transplantation [J] . Haider Mahnur, Gangat Naseema, Hanson Curtis, American Journal of Hematology . 2016,第5期

机译：在HCT-CI中用于调节血红蛋白DLCO的Dinakara方程优于预测同种异体造血干细胞移植中高危患者的Cotes方程
2. The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission [J] . WangL., WangY., TangW., International journal of hematology . 2013,第5期

机译：高危急性淋巴细胞白血病初次缓解的成年患者从无关供体的同种异体造血干细胞移植优于化疗的优势
3. The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission [J] . Ling Wang, Ying Wang, Wei Tang, International Journal of Hematology . 2013,第5期

机译：高危急性淋巴细胞白血病初次缓解的成年患者从无关供体的同种异体造血干细胞移植优于化疗的优势
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation [O] . Pere Barba, Ravin Ratan, Christina Cho, -1

机译：造血细胞移植合并症指数（HCT-CI）预测接受CD34 +选择的异基因造血细胞移植的急性髓性白血病和骨髓增生异常综合症患者的预后
7. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation [O] . FARINA L, BRUNO B, PATRIARCA F, 2009

机译：降低强度或非清髓性同种异体干细胞移植后，造血细胞移植合并症指数（HCT-CI）预测淋巴瘤和骨髓瘤患者的临床结局

The Dinakara equation for adjusting DLCO for hemoglobin in the HCT-CI is superior to the Cotes equation for predicting high-risk patients in allogeneic hematopoietic stem cell transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅